|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,958.00 DKK | -1.48% |
|
-3.17% | -3.40% |
| 04/02 | Goldman Sachs Lowers Price Target for Genmab to 1,793 Danish Kroner (from 1,880), Reiterates Neutral - BN | FW |
| 04/02 | Fitch Highlights Genmab's Antibody Oncology Leadership in Final Rating | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | 16.61x | 3.19x | 3.9x | 10.31x | 10.91x | 1.91TCr | ||
| 0.02% | 0.04% | 46.3x | 7.32x | 11.02x | 39.36x | 40.39x | 5.03TCr | ||
| 1.77% | 1.59% | 16.91x | 4.05x | 6.04x | 13.29x | 14.51x | 4.21TCr | ||
| -.--% | -.--% | -25.72x | 75.02x | 51.77x | -29.4x | -27.74x | 3.2TCr | ||
| -.--% | -.--% | -26.38x | 1.21x | 4.43x | -12.22x | -9.64x | 2.68TCr | ||
| -.--% | -.--% | 30.86x | 2.86x | 6.1x | 16.89x | 21.03x | 1.99TCr | ||
| -.--% | -.--% | -175.88x | 22.09x | 43.39x | -175.79x | -155.67x | 1.26TCr | ||
| -.--% | -.--% | -306.26x | 10.49x | 24.05x | 1011.94x | -306.64x | 1.19TCr | ||
| -.--% | -.--% | 16.6x | 4.52x | 4.78x | 11.62x | 12.87x | 1.18TCr | ||
| -.--% | -.--% | -11.37x | - | 142.01x | -22.14x | -11.14x | 1.16TCr | ||
| -.--% | -.--% | -44.51x | 19.12x | 10.89x | -37.86x | -40.57x | 1.08TCr | ||
| -.--% | -.--% | -20.13x | 16.8x | 17.31x | -28.06x | -20.74x | 903.49Cr | ||
| 0.18% | 0.29% | 52.45x | 8.37x | 15.94x | 47.92x | 51.78x | 845.08Cr | ||
| -.--% | -.--% | -18.1x | 7.8x | - | -18.6x | -17.97x | 804.45Cr | ||
| -.--% | -.--% | -10.12x | - | - | -9.32x | -8.87x | 806.07Cr | ||
| Average | 0.13% | 0.13% | -30.58x | 14.07x | 26.28x | 54.53x | -29.83x | 1.88TCr | |
| Weighted average by Cap. | 0.27% | 0.25% | -13.46x | 15.36x | 21.47x | 39.01x | -13.71x |
- Stock Market
- Equities
- GMAB Stock
- Sector Genmab A/S
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















